Christian M. Spaulding
Director/Board Member chez STENTYS
Profil
Christian M.
Spaulding is currently an Independent Director at Stentys SA, Head of the Interventional Cardiology Department at Hôpital Européen Georges-pompidou, Chief Medical Advisor at Techwald Holding SPA, and a Member of the Cardiac Arrest Research Centre at Paris Research Center Cardiovasculaire.
He previously worked as Vice President of Medical Affairs at Cordis Corp.
and as a Professor at Université de Paris 5 René Descartes.
Postes actifs de Christian M. Spaulding
| Sociétés | Poste | Début |
|---|---|---|
| STENTYS | Director/Board Member | 31/03/2017 |
| Hôpital Européen Georges-pompidou | Corporate Officer/Principal | - |
| Paris Research Center Cardiovasculaire | Corporate Officer/Principal | - |
Techwald Holding SPA
 Techwald Holding SPA Investment ManagersFinance Techwald Holding SPA (TechWald) is a private equity/venture capital firm founded in 2017 by Alessandro Piga, Doron Cohen and Tommaso Zambelli. The firm is headquartered in Turin, Italy. | Corporate Officer/Principal | - |
Anciens postes connus de Christian M. Spaulding
| Sociétés | Poste | Fin |
|---|---|---|
| Université de Paris 5 René Descartes | Corporate Officer/Principal | - |
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Chief Tech/Sci/R&D Officer | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
Stentys SA
 Stentys SA Medical SpecialtiesHealth Technology Stentys SA engages in the design, development, and marketing of self-expanding stents used in treating cardiovascular diseases. It provides solutions for the treatment of acute myocardial infarction and other complex coronary diseases. Its products include Xposition S, Devoir, AmazoniaSir, stemiCath, Yangtzenano and YangtzeNC. The company was founded by Gonzague Issenmann and Jacques Seguin on July 6, 2006 and is headquartered in Neuilly-sur-Seine, France. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
Techwald Holding SPA
Techwald Holding SPA Investment ManagersFinance Techwald Holding SPA (TechWald) is a private equity/venture capital firm founded in 2017 by Alessandro Piga, Doron Cohen and Tommaso Zambelli. The firm is headquartered in Turin, Italy. | Finance |
| Paris Research Center Cardiovasculaire | |
| Hôpital Européen Georges-pompidou |
